
Matt Kalaycio
Director, Bone Marrow Transplant Program · Cleveland Clinic Foundation
Credentials: · · ·
History
1991–1992- 1988–1991
UPMC Mercy Hospital of Pittsburgh

1980–1984
Research
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Blood · 2014 · 858 citations
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
Journal of Clinical Oncology · 2001 · 661 citations
Leukemia · 2014 · 255 citations

150 papers · 1 as a fellow
- BB
111 papers
- BP
105 papers

79 papers · 1 as a fellow

70 papers
- SA
67 papers

65 papers · 4 as a fellow

62 papers
Clinical trials
- 2008–2013
Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
Principal investigator · Terminated · Phase 1
Case Comprehensive Cancer Center
- 2004–2008
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2009–2010
Study chair · Withdrawn · Phase 2
SWOG Cancer Research Network
- 2001–2008
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Study chair · Completed · Phase 2
The Cleveland Clinic


